FP7-33259-67169
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 781 / TX
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-28
- 2021-01-04
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-13
- 2021-01-14
- 2021-01-16
- 2021-01-23
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-11
- 2021-07-10
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Headache — Feeling: Good · Site: Pain · Muscle or body achesFree text: Headache last nightMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-05
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID 1/10/22MedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Survey response — 12 months, dose 3MedDRA: Conjunctivitis, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Fever, pink eyeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-04
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Headache last night
Release 11 — 6 months, dose 3
Symptoms: Tested positive for COVID 1/10/22
Release 12 — 12 months, dose 3
Symptoms: Fever, pink eye
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release